USTEKINISU

A multicenter phase 2 single-arm proof-of-concept trial assessing the efficacy and safety of ustekinumab in association with prednisone, for the treatment of non-infectious severe uveitis (NISU)

Type: Interventional

Status of the trial: Active, Recruiting

Orphan Drug Recognition: Yes

Inclusion

Opening Date: 2019-08-01
Closing Date: 2022-01-01

Criteria

More information

Children: No

Adults: Yes

Funder Type: public

HCP: Principal investigators

HCP: Other investigators

Within ERN-EYE members

Principal investigators

Other investigators

Workgroups

Anterior Segment Rare Eye Diseases (WG4)

USTEKINISU

Within ERN-EYE members

Subscribe

This ERN is supported by: